Clinical Outcomes and Medical Care Costs Among Medicare Beneficiaries Receiving Therapy for Peripheral Arterial Disease

Annals of Vascular Surgery

Volumn 24, Issue 5, 2010, Pages 577-587

  Jaff, Michael R ^a   Cahill, Kevin E ^b   Yu, Andrew P ^b   Birnbaum, Howard G ^b   Engelhart, Luella M ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ANALYSIS GROUP   (United States)

^c Johnson Johnson Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMPUTATION; ARTERY DISEASE; ARTICLE; ATHERECTOMY; BYPASS SURGERY; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; COST EFFECTIVENESS ANALYSIS; DEATH; DIABETES MELLITUS; ENDARTERECTOMY; ENDOVASCULAR SURGERY; FEMALE; HAZARD RATIO; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPULATION RISK; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOM SAMPLE; REVASCULARIZATION; STENT; SURGICAL TECHNIQUE; ADVERSE EFFECTS; COST BENEFIT ANALYSIS; DEVICES; ECONOMICS; INSURANCE; PERIPHERAL VASCULAR DISEASES; PREVALENCE; PROPORTIONAL HAZARDS MODEL; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; VASCULAR SURGERY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; COST-BENEFIT ANALYSIS; DIABETES MELLITUS; FEMALE; HEALTH CARE COSTS; HUMANS; INSURANCE BENEFITS; MALE; MEDICARE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERIPHERAL VASCULAR DISEASES; PREVALENCE; PROPORTIONAL HAZARDS MODELS; STENTS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASCULAR SURGICAL PROCEDURES;

EID: 77953304429     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2010.03.015     Document Type: Article

References (17)

1. Rosamond W., Flegal K., Furie K., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
2. Newman A.B. Peripheral arterial disease: insights from population studies of older adults. J Am Geriatr Soc 48 (2000) 1157-1162
3. Ostchega Y., Paulose-Ram R., Dillon C.F., Gu Q., and Hughes J.P. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc 55 (2007) 583-589
4. Hirsch A.T., Murphy T.P., Lovell M.B., et al. Peripheral Arterial Disease Coalition. Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation 116 (2007) 2086-2094
5. Gardner A.W., and Poehlman E.T. Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis. JAMA 274 (1995) 975-980
6. Regensteiner J., Ware Jr. J.E., McCarthy W.J., et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc 50 (2002) 1939-1946
7. Ouriel K. Peripheral arterial disease. Lancet 358 (2001) 1257-1264
8. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
9. Steg P.G., Bhatt D.L., Wilson P.W., et al. REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297 (2007) 1197-1206
10. Welten G.M., Schouten O., Hoeks S.E., et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol 51 (2008) 1588-1596
11. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
12. Ryan J, Linde-Zwirble W, Engelhart L, Cooper L, Cohen D. Temporal trends in coronary revascularization procedures, outcomes, and costs: results from the U.S. Medicare Program. Paper presented at: Transcatheter Cardiovascular Therapeutics 19th Annual Scientific Symposium, October 20-25, 2007, Washington, DC.
13. Criqui M.H., Fronek A., Klauber M.R., Barrett-Connor E., and Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 71 (1985) 516-522
14. Fowkes F.G., Housley E., Cawood E.H., et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20 (1991) 384-392
15. Meijer W.T., Hoes A.W., Rutgers D., et al. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol 18 (1998) 185-192
16. Hirsch A.T., Hartman L., Town R.J., and Virnig B.A. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med 13 (2008) 209-215
17. Diehm C., Schuster A., Allenberg J.R., et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172 (2004) 95-105